NYSE:HUM
Humana Inc Stock News
$358.12
+10.74 (+3.09%)
At Close: May 31, 2024
Humana Elects Marcy S. Klevorn and Jorge S.
07:05am, Thursday, 18'th Feb 2021
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that Marcy S. Klevorn and Jorge S. Mesquita have been elected as members of the company's board of directors. Marcy S. Klevorn
Humana Board Declares Payment of Quarterly Dividend to Stockholders
07:00am, Thursday, 18'th Feb 2021
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.70 per share payable on April 30, 2021 to stock
Humana (HUM) Joins IBM Watson Health to Aid Member Experience
04:02pm, Monday, 15'th Feb 2021
Humana (HUM) teams up with IBM Watson Health to leverage the latter's conversational AI solution for providing better information to Humana Employer Group members.
Signify Health Pursues $423 Million IPO
03:27pm, Thursday, 04'th Feb 2021
Signify Health has filed proposed terms for its U.S. IPO. The firm provides a platform to increased healthcare system efficiencies through value-based care.
Humana Inc. (HUM) CEO Bruce Broussard on Q4 2020 Results - Earnings Call Transcript
12:28pm, Wednesday, 03'rd Feb 2021
Humana Inc. (HUM) CEO Bruce Broussard on Q4 2020 Results - Earnings Call Transcript
Humana's (HUM) Q4 Loss Narrower Than Expected, Tumble Y/Y
12:07pm, Wednesday, 03'rd Feb 2021
Humana's (HUM) fourth-quarter results reflect elevated costs related to COVID-19 along with high marketing expenses.
Humana Hit Hard By Covid-19 Costs As Medicare Advantage Enrollment Rises
09:34am, Wednesday, 03'rd Feb 2021
Humana reported a $458 million fourth quarter loss as the health insurer was hit by costs related to the Covid-19 pandemic and the expense of testing and treating these patients in the last two months
Humana (HUM) Reports Q4 Loss, Tops Revenue Estimates
09:06am, Wednesday, 03'rd Feb 2021
Humana (HUM) delivered earnings and revenue surprises of 2.13% and 1.26%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Humana: Q4 Earnings Insights
07:23am, Wednesday, 03'rd Feb 2021
Shares of Humana (NYSE:HUM) remained unaffected after the company reported Q4 results. Quarterly Results Earnings per share fell 200.88% over the past year to ($2.30), which beat the estimate of ($2.3
Humana Reports Fourth Quarter 2020 Financial Results; Provides Full Year 2021 Financial Guidance
06:30am, Wednesday, 03'rd Feb 2021
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and results per common share for the quarter ended December 31, 2020 (4Q20) versus the quarter ende
Humana (HUM) to Report Q4 Earnings: What's in the Cards?
11:22am, Monday, 01'st Feb 2021
Humana's (HUM) fourth-quarter 2020 earnings might have endured escalating COVID-related expenses, partly offset by better revenues.
Humana Selected by Oklahoma Health Care Authority to Serve Medicaid Beneficiaries
04:05pm, Friday, 29'th Jan 2021
OKLAHOMA CITY--(BUSINESS WIRE)--Leading health and well-being company Humana Inc. (NYSE: HUM) has been selected by the Oklahoma Health Care Authority (OHCA) to deliver health care coverage to Medicaid
Humana to Begin Serving Medicaid Managed Care and Dual Eligible Residents in South Carolina
04:05pm, Wednesday, 27'th Jan 2021
LOUISVILLE, Ky.--(BUSINESS WIRE)--The South Carolina Department of Health and Human Services (SCDHHS) has added Humana Inc. (NYSE: HUM) to its Healthy Connections Medicaid program and its Healthy Conn
Monogram Health Announces Availability of Kidney Disease Care Coordination Services for Humana Members in Tennessee and Alabama
10:09am, Tuesday, 26'th Jan 2021
NASHVILLE, Tenn., Jan. 26, 2021 /PRNewswire/ -- Monogram Health announced today that it is expanding its collaboration with leading health and wellness company Humana Inc. (NYSE: HUM). Through an agre
The next wave of vaccines — Humana's answer to buzzy startups — Calico's hiring
08:49am, Monday, 25'th Jan 2021
Hello, Happy Monday! We're starting off the day with some fresh vaccine news. First, Merck is discontinuing its COVID-19 vaccine trials, a major setback from the company that developed the only Ebola